161 related articles for article (PubMed ID: 16321660)
1. Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM.
Coppola G; Corrado E; Muratori I; Tantillo R; Vitale G; Lo Coco L; Novo S
Int J Cardiol; 2006 Jan; 106(1):16-20. PubMed ID: 16321660
[TBL] [Abstract][Full Text] [Related]
2. Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions.
Corrado E; Rizzo M; Muratori I; Coppola G; Novo S
Menopause; 2008; 15(2):240-7. PubMed ID: 17917609
[TBL] [Abstract][Full Text] [Related]
3. [Predictive value of fibrinogen and high-sensitivity C-reaction protein for cardiovascular events in patients with stable coronary artery disease].
Huang W; Chen QW; Lei H; Deng W; Ke DZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Aug; 34(8):718-21. PubMed ID: 17081398
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk factors in obese women and their first-degree relatives.
Saraç F; Ozgen AG; Yilmaz C; Tüzün M
Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome.
Linnemann B; Voigt W; Nobel W; Janka HU
Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):127-34. PubMed ID: 16636979
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP).
Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Dressler D; Seifried E; Lindhoff-Last E
Thromb Haemost; 2009 Oct; 102(4):668-75. PubMed ID: 19806251
[TBL] [Abstract][Full Text] [Related]
7. Carotid and peripheral atherosclerosis in patients who underwent primary percutaneous coronary intervention and outcome associated with multifocal atherosclerosis.
Romano G; Corrado E; Muratori I; Novo G; Andolina G; Cospite V; Evola S; Ciaramitaro GF; Di Vincenzo A; Farinella M; Rotolo A; Assennato P; Hoffmann E; Novo S
Int Angiol; 2006 Dec; 25(4):389-94. PubMed ID: 17164746
[TBL] [Abstract][Full Text] [Related]
8. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
[TBL] [Abstract][Full Text] [Related]
9. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.
Tekin IO; Pocan B; Borazan A; Ucar E; Kuvandik G; Ilikhan S; Demircan N; Ozer C; Kadayifci S
Ren Fail; 2008; 30(2):219-25. PubMed ID: 18300125
[TBL] [Abstract][Full Text] [Related]
10. Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.
Sinning JM; Bickel C; Messow CM; Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Lackner KJ; Tiret L; Münzel T; Blankenberg S;
Eur Heart J; 2006 Dec; 27(24):2962-8. PubMed ID: 17132649
[TBL] [Abstract][Full Text] [Related]
11. The predictive role of C-reactive protein in patients with hypertension and subclinical atherosclerosis.
Rizzo M; Corrado E; Coppola G; Muratori I; Mezzani A; Novo G; Novo S
Intern Med J; 2009 Aug; 39(8):539-45. PubMed ID: 19323703
[TBL] [Abstract][Full Text] [Related]
12. Association between future events of brain infarction and soluble levels of intercellular adhesion molecule-1 and C-reactive protein in patients with type 2 diabetes mellitus.
Kanai A; Kawamura T; Umemura T; Nagashima M; Nakamura N; Nakayama M; Sano T; Nakashima E; Hamada Y; Nakamura J; Hotta N
Diabetes Res Clin Pract; 2008 Nov; 82(2):157-64. PubMed ID: 18692933
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study on the correlation between high sensitivity C-reactive protein and risk factors in cerebral vessel [corrected] disease].
Zhou WJ; Tong JJ; Ye J; Lu YM
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jun; 19(6):325-8. PubMed ID: 17577433
[TBL] [Abstract][Full Text] [Related]
14. Value of C-reactive protein levels and IL-6 in predicting events levels in women at increased cardiovascular risk.
Vitale C; Gebara O; Mercuro G; Wajngarten M; Silvestri A; Rossini P; Ramires JA; Fini M; Rosano GM
Maturitas; 2005 Apr; 50(4):239-46. PubMed ID: 15780522
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
16. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
[TBL] [Abstract][Full Text] [Related]
17. High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome.
Aso Y; Wakabayashi S; Nakano T; Yamamoto R; Takebayashi K; Inukai T
Metabolism; 2006 Aug; 55(8):1014-21. PubMed ID: 16839835
[TBL] [Abstract][Full Text] [Related]
18. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
[TBL] [Abstract][Full Text] [Related]
19. One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease.
Avellone G; Di Garbo V; Abruzzese G; Campisi D; De Simone R; Raneli G; Licata G
Int Angiol; 2006 Mar; 25(1):26-34. PubMed ID: 16520721
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein gene C1444T polymorphism and risk of recurrent ischemic events in patients with symptomatic intracranial atherostenoses.
Arenillas JF; Massot A; Alvarez-Sabín J; Fernandez-Cadenas I; del Rio-Espinola A; Chacon P; Quintana M; Molina CA; Rovira A; Montaner J
Cerebrovasc Dis; 2009; 28(1):95-102. PubMed ID: 19494488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]